Substantial Medicare Savings May Result if Insurers Cover 'Artificial Pancreas' Sooner for Diabetes Patients

Health Affairs - United States
doi 10.1377/hlthaff.2011.1052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

HIV and Insurance. Insurers Don't Penalise if Test Result Is Negative.

BMJ
1993English

Pancreas Transplantation for Patients With Diabetes Mellitus

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1992English

Encouraging Insurers to Regulate: The Role (If Any) for Tort Law

SSRN Electronic Journal
2015English

Automated Closed-Loop Control of Diabetes: The Artificial Pancreas

Bioelectronic Medicine
2018English

Insurers’ Response to Selection Risk: Evidence From Medicare Enrollment Reforms

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pmd62 - Advancement in Self-Monitoring of Blood Glucose (Smbg) Technology Improves Metabolic Control, Diabetes Management and Patient Satisfaction in Patients With Diabetes and Has the Potential for Substantial Cost Savings for the German Health System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cybersecurity in Artificial Pancreas Experiments

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2015English

Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2018English

010–Automated Insulin Delivery (Artificial Pancreas) on the Horizon: Educational Considerations for Youth With Type 1 Diabetes

Journal of Pediatric Nursing
Pediatrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy